0009
Hunan Jingfeng Pharmaceutical Co., Ltd. (000908)
Market Closed
25 Jul, 06:57
XSHE XSHE Primary ¥
5. 88
+0.14
+2.44%
¥
5.14B Market Cap
- P/E Ratio
0.04% Div Yield
15,518,470 Volume
0 Eps
¥ 5.74
Previous Close Day Range
5.72 5.99
Year Range
1.59 6.6
Want to track 000908 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
000908 closed today higher at ¥5.88, an increase of 2.44% from yesterday's close, completing a monthly increase of or ¥5.88. Over the past 12 months, 000908 stock gained .
000908 is not paying dividends to its shareholders.
The last earnings report, released on May 30, 2025, missed the consensus estimates by -0.01%. On average, the company has surpassed earnings expectations by 0.02%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSHE (CNY).
000908 Chart
Hunan Jingfeng Pharmaceutical Co., Ltd. Dividends
| 0009 000908 23 Aug 2018 | Other | ¥0.01 Per Share |
| 0009 000908 23 Jun 2016 | Other | ¥0.09 Per Share |
| 0009 000908 6 Jul 2004 | Other | ¥0.03 Per Share |
| 0009 000908 19 Jul 2001 | Other | ¥0.03 Per Share |
Hunan Jingfeng Pharmaceutical Co., Ltd. Earnings
| 30 May 2025 Date | | - Cons. EPS | - EPS |
| 30 May 2024 Date | | - Cons. EPS | 0 EPS |
| 27 Oct 2016 Date | | - Cons. EPS | 0.06 EPS |
| 24 Aug 2016 Date | | - Cons. EPS | 0.09 EPS |
| 28 Apr 2016 Date | | - Cons. EPS | 0.05 EPS |
| 0009 000908 23 Aug 2018 | Other | ¥0.01 Per Share |
| 0009 000908 23 Jun 2016 | Other | ¥0.09 Per Share |
| 0009 000908 6 Jul 2004 | Other | ¥0.03 Per Share |
| 0009 000908 19 Jul 2001 | Other | ¥0.03 Per Share |
| 30 May 2025 Date | | - Cons. EPS | - EPS |
| 30 May 2024 Date | | - Cons. EPS | 0 EPS |
| 27 Oct 2016 Date | | - Cons. EPS | 0.06 EPS |
| 24 Aug 2016 Date | | - Cons. EPS | 0.09 EPS |
| 28 Apr 2016 Date | | - Cons. EPS | 0.05 EPS |
Hunan Jingfeng Pharmaceutical Co., Ltd. (000908) FAQ
What is the stock price today?
The current price is ¥5.88.
On which exchange is it traded?
Hunan Jingfeng Pharmaceutical Co., Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 000908.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.04%.
What is its market cap?
As of today, the market cap is 5.14B.
Has Hunan Jingfeng Pharmaceutical Co., Ltd. ever had a stock split?
No, there has never been a stock split.
Hunan Jingfeng Pharmaceutical Co., Ltd. Profile
| Drug Manufacturers - General Industry | Healthcare Sector | Ms. Li Zhang CEO | XSHE Exchange | CNE000000Y11 ISIN |
| CN Country | 547 Employees | - Last Dividend | 23 Jun 2016 Last Split | 18 Nov 1998 IPO Date |
Overview
Hunan Jingfeng Pharmaceutical Co., Ltd., established in 2003 and based in Shanghai, China, is engaged in the manufacturing and sale of chemical drugs and biological agents across the country. The company has carved out a niche in the pharmaceutical industry through its focus on sodium hyaluronate injection, primarily used in orthopedics and surgery applications. Expanding its portfolio, Hunan Jingfeng Pharmaceutical also invests in the research and development of novel therapeutics targeting major health concerns such as tumors, cancer, and cardiovascular diseases. In addition to its product offerings, the company extends its expertise by providing comprehensive Contract Development and Manufacturing Organization (CDMO) and Contract Manufacturing Organization (CMO) services, leveraging its advanced technological capabilities and industry experience.
Products and Services
- Sodium Hyaluronate Injection: The flagship product of Hunan Jingfeng Pharmaceutical, designed for orthopedic and surgical use, exemplifies the company's commitment to advancing medical care through innovative treatments.
- Ophthalmology Products: The company offers a range of products tailored for eye health, underscoring its dedication to addressing a wide spectrum of medical needs.
- API (Active Pharmaceutical Ingredients): Hunan Jingfeng Pharmaceutical provides high-quality active pharmaceutical ingredients, demonstrating its capability in supporting the broader pharmaceutical industry with essential components for drug development and manufacturing.
- Anti-Tumor, Cancer, and Cardiovascular Drug R&D: Engaged in the research and development of cutting-edge drugs to combat tumors, cancer, and cardiovascular diseases, the company takes an active part in the global fight against some of the most challenging health issues.
- Skin Care Products: Expanding its product range beyond pharmaceuticals, Hunan Jingfeng Pharmaceutical also offers skin care products, emphasizing its aim to enhance overall well-being and quality of life.
- CDMO/CMO Services: With comprehensive Contract Development and Manufacturing Organization (CDMO) and Contract Manufacturing Organization (CMO) services, Hunan Jingfeng Pharmaceutical positions itself as a versatile partner in the pharmaceutical and biotechnology sectors, offering end-to-end solutions from development to manufacturing.
Contact Information
Address: No. 2288 Shitai Road, Shanghai, China, 201908
Phone: 86 21 6686 1001
Website: https://www.jfzhiyao.com
2025 © Marketlog. All Rights Reserved.
